Clinical Trials in Vsevolozhsk, Russia
1 recruiting
Showing 1–2 of 2 trials
Recruiting
Phase 3
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
Cardiovascular Disease and Lipoprotein(a)
Novartis Pharmaceuticals5,700 enrolled492 locationsNCT07517263
Recruiting
Phase 3
The Study of Efficacy and Safety of Dimephosphon® in Acute Ischemic Stroke
StrokeCerebrovascular DisordersAcute Stroke+2 more
Tatchempharmpreparaty, JSC184 enrolled6 locationsNCT07167550